• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How vision and leadership shaped the U.S. National Cancer Institute's 50-year journey to advance the evidence base of cancer control and cancer care delivery research.愿景与领导力如何塑造了美国国立癌症研究所推动癌症控制与癌症护理交付研究证据基础的50年征程。
Health Policy Open. 2020 Dec;1:100015. doi: 10.1016/j.hpopen.2020.100015. Epub 2020 Oct 13.
2
The NCI All Ireland Cancer Conference.美国国家癌症研究所全爱尔兰癌症会议。
Oncologist. 1999;4(4):275-277.
3
Speeding implementation in cancer: The National Cancer Institute's Implementation Science Centers in Cancer Control.加速癌症防治实施:美国国家癌症研究所癌症控制实施科学中心。
J Natl Cancer Inst. 2023 Feb 8;115(2):131-138. doi: 10.1093/jnci/djac198.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
National Cancer Institute partnerships in quality-of-care research.国家癌症研究所合作开展医疗质量研究。
Cancer Control. 2009 Oct;16(4):283-92. doi: 10.1177/107327480901600402.
6
The Outcomes of Cancer Outcomes Research: focusing on the National Cancer Institute's quality-of-care initiative.癌症结局研究的成果:聚焦于美国国立癌症研究所的医疗质量倡议。
Med Care. 2002 Jun;40(6 Suppl):III3-10.
7
Bridging the gap between research, policy, and practice: Lessons learned from academic-public partnerships in the CTSA network.弥合研究、政策与实践之间的差距:从临床与转化科学奖(CTSA)网络中的学术-公共伙伴关系中汲取的经验教训。
J Clin Transl Sci. 2020 Mar 10;4(3):201-208. doi: 10.1017/cts.2020.23.
8
Five strategies for accelerating the war on cancer in an era of budget deficits.在预算赤字时代加速抗癌之战的五项策略。
Oncologist. 2009 Feb;14(2):110-6. doi: 10.1634/theoncologist.2008-0270. Epub 2009 Jan 15.
9
The National Cancer Institute's Role in Advancing Health-Care Delivery Research.国家癌症研究所在推进医疗保健提供研究方面的作用。
J Natl Cancer Inst. 2022 Jan 11;114(1):20-24. doi: 10.1093/jnci/djab096.
10
The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.医院环境中患者与护士以患者为中心的沟通体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):76-87. doi: 10.11124/jbisrir-2015-1072.

引用本文的文献

1
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.实体瘤的早期药物开发:美国国家癌症研究所资助的 I 期临床试验分析。
Lancet. 2022 Aug 13;400(10351):512-521. doi: 10.1016/S0140-6736(22)01390-3.
2
A History of Health Economics and Healthcare Delivery Research at the National Cancer Institute.国家癌症研究所卫生经济学和医疗服务提供研究的历史。
J Natl Cancer Inst Monogr. 2022 Jul 5;2022(59):21-27. doi: 10.1093/jncimonographs/lgac003.
3
Achieving a multilevel evidence-based approach to improve cancer care in the U.S. post-COVID era: What is the role of management?实现基于多层次循证的方法来改善美国后 COVID 时代的癌症护理:管理的作用是什么?
J Cancer Policy. 2022 Mar;31:100307. doi: 10.1016/j.jcpo.2021.100307. Epub 2021 Sep 29.
4
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute.血液系统恶性肿瘤I期试验中5级毒性和反应的趋势:美国国立癌症研究所癌症治疗评估项目20年经验
J Clin Oncol. 2022 Jun 10;40(17):1949-1957. doi: 10.1200/JCO.21.02190. Epub 2022 Mar 9.
5
Behavioral Research in Cancer Prevention and Control: Emerging Challenges and Opportunities.癌症预防与控制中的行为研究:新的挑战与机遇。
J Natl Cancer Inst. 2022 Feb 7;114(2):179-186. doi: 10.1093/jnci/djab139.
6
The National Cancer Institute's Role in Advancing Health-Care Delivery Research.国家癌症研究所在推进医疗保健提供研究方面的作用。
J Natl Cancer Inst. 2022 Jan 11;114(1):20-24. doi: 10.1093/jnci/djab096.

本文引用的文献

1
Evolution of Cancer Care Delivery Research in the NCI Community Oncology Research Program.NCI 社区肿瘤学研究计划中癌症护理提供研究的演变。
J Natl Cancer Inst. 2020 Jun 1;112(6):557-561. doi: 10.1093/jnci/djz234.
2
Evidence, values, and funding decisions in Canadian cancer systems.加拿大癌症系统中的证据、价值观与资金决策。
Healthc Manage Forum. 2019 Nov;32(6):293-298. doi: 10.1177/0840470419870831. Epub 2019 Sep 4.
3
Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and Policy.制定癌症生存者照护质量框架:对临床照护、研究和政策的影响。
J Natl Cancer Inst. 2019 Nov 1;111(11):1120-1130. doi: 10.1093/jnci/djz089.
4
Conceptualizing De-Implementation in Cancer Care Delivery.癌症护理服务中去实施的概念化
J Clin Oncol. 2019 Jan 10;37(2):93-96. doi: 10.1200/JCO.18.00589. Epub 2018 Nov 8.
5
Strategies to Achieve High-Value Oncology Care-A Beginning.实现高价值肿瘤护理的策略——开端
JAMA Oncol. 2018 Feb 1;4(2):171-172. doi: 10.1001/jamaoncol.2017.3794.
6
New Directions in Cancer Control and Population Sciences.癌症控制与人口科学的新方向
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1165-1169. doi: 10.1158/1055-9965.EPI-16-1022.
7
The Oncology Care Model: Perspectives From the Centers for Medicare & Medicaid Services and Participating Oncology Practices in Academia and the Community.肿瘤护理模式:来自医疗保险和医疗补助服务中心以及学术和社区参与肿瘤治疗机构的观点。
Am Soc Clin Oncol Educ Book. 2017;37:460-466. doi: 10.1200/EDBK_174909.
8
Overuse of Health Care Services in the Management of Cancer: A Systematic Review.癌症管理中医疗保健服务的过度使用:一项系统综述。
Med Care. 2017 Jul;55(7):723-733. doi: 10.1097/MLR.0000000000000734.
9
Prime Time for Shared Decision Making.共同决策的黄金时机。
JAMA. 2017 Apr 4;317(13):1309-1310. doi: 10.1001/jama.2017.0616.
10
National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.现代筛查数字化乳腺摄影的国家性能基准:来自乳腺癌监测联盟的更新
Radiology. 2017 Apr;283(1):49-58. doi: 10.1148/radiol.2016161174. Epub 2016 Dec 5.

愿景与领导力如何塑造了美国国立癌症研究所推动癌症控制与癌症护理交付研究证据基础的50年征程。

How vision and leadership shaped the U.S. National Cancer Institute's 50-year journey to advance the evidence base of cancer control and cancer care delivery research.

作者信息

Kaluzny Arnold D, O'Brien Donna M

机构信息

Gillings School of Global Public Health, Cecil G. Sheps Center for Health Services Research, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

Strategic Visions in Healthcare LLC, New York, NY, United States of America.

出版信息

Health Policy Open. 2020 Dec;1:100015. doi: 10.1016/j.hpopen.2020.100015. Epub 2020 Oct 13.

DOI:10.1016/j.hpopen.2020.100015
PMID:33073235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7550860/
Abstract

In 1971, Congress passed the National Cancer Act, landmark legislation that reorganized the National Institutes of Health's National Cancer Institute (NCI). The Act included a new focus on cancer control, including the requirement that the NCI award research grants and contracts, in collaboration with other public agencies and private industry, to conduct cancer control activities related to the diagnosis, prevention, and treatment of cancer. The requirement placed the NCI at the nexus of a rapidly changing science and a complex and dynamic healthcare delivery system and involved an evolutionary transformation to advance cancer control and cancer care delivery research along the cancer care continuum. Analysis is based on a qualitative ethnographic approach using historical records, oral histories, and targeted interviews. The multimethod approach provided the opportunity to describe the vision, leadership, and struggle to build an infrastructure, expand expertise, and forge collaboration with the NCI and a complex and changing healthcare system. As the 50th anniversary of the National Cancer Act approaches in 2021, the process and these achievements are at risk of being taken for granted or lost in the flow of history. Documenting the process, milestones, and key players provides insight and guidance for continuing to improve cancer care, advance research, and reduce cancer incidence and mortality. Cancer care is a microcosm of the larger healthcare system providing insight and lessons on the importance of developing and maintaining a research infrastructure and the role of multi-level collaboration and partnerships involving both the private and public sectors.

摘要

1971年,美国国会通过了《国家癌症法案》,这是一项具有里程碑意义的立法,对美国国立卫生研究院的国家癌症研究所(NCI)进行了重组。该法案包括对癌症控制的新关注,其中要求NCI与其他公共机构和私营企业合作,授予研究补助金和合同,以开展与癌症诊断、预防和治疗相关的癌症控制活动。这一要求使NCI处于快速变化的科学与复杂且动态的医疗保健服务系统的交汇处,并涉及到一场渐进式变革,以在癌症护理连续过程中推进癌症控制和癌症护理服务研究。分析基于一种定性的人种志方法,使用历史记录、口述历史和定向访谈。这种多方法途径提供了机会,来描述构建基础设施、扩大专业知识以及与NCI和复杂多变的医疗保健系统建立合作关系的愿景、领导力和奋斗历程。随着2021年《国家癌症法案》50周年纪念日的临近,这一过程和这些成就有被视为理所当然或在历史长河中被遗忘的风险。记录这一过程、里程碑和关键人物,可为持续改善癌症护理、推进研究以及降低癌症发病率和死亡率提供见解和指导。癌症护理是更大的医疗保健系统的一个缩影,它为发展和维持研究基础设施的重要性以及公私部门多层次合作与伙伴关系的作用提供了见解和经验教训。